AI drug discovery has a data problem. We're fixing it. At ALLOX, we've spent the last few years building something that didn't exist before: a platform that systematically maps functional hotspots at scale, measuring the effects of mutations on protein-protein interactions across the proteome.
Welcome back from the break! Next up @juliadiumenge.bsky.social from @alloxbio.bsky.social Mapping allosteric sites at scale to develop better drugs
#PCBCommunity |đ§Ź @alloxbio.bsky.social ha desenvolupat una #tecnologia Ășnica per abordar un dels grans enigmes de la biologia: la regulaciĂł al·lostĂšrica de les #proteĂŻnes, identificant els llocs al·lostĂšrics i convertint-los en noves dianes terapĂšutiques per desenvolupar #tractaments mĂ©s efectius. đ
ALLOX, la startup que explora lâal·losterisme per revolucionar el desenvolupament de nous fĂ rmacs - Parc CientĂfic de Barcelona
Lâempresa techbio acaba dâinstal·lar-se al Parc CientĂfic i es perfila com una de les startups mĂ©s prometedores de la biotecnologia catalana.
pcb.ub.edu
At ALLOX @alloxbio.bsky.social in Barcelona we now have 3 computational positions available! đStructural Bioinformatics Scientist đ tinyurl.com/3rs46j4t đPlatform Bioinformatician đ tinyurl.com/nyvazbke đComputational Chemist đ tinyurl.com/5n6vpem3 Apply or repost to help us spread the word đ